Earlier this year, The Lancet Respiratory Medicine reported staggering for the number of people aged 30–69 years who are affected by obstructive sleep apnoea (OSA). The figure of nearly a billion adults with mild to severe OSA suggests that the condition is both underdiagnosed and under-recognised. The paper also highlighted the paucity of quality evidence available to derive estimates of the prevalence and burden of OSA. To provide such global data is important because the condition, especially severe OSA, is associated with neurocognitive impairment, reduced quality of life, and an increased risk of hypertension, cancer, and metabolic, cardiovascular, and cerebrovascular diseases.

中文翻译：

---

是时候唤醒巨大的阻塞性睡眠呼吸暂停了。

今年早些时候，《柳叶刀》呼吸医学报道了受阻塞性睡眠呼吸暂停（OSA）影响的30-69岁年龄段的人数惊人。约有十亿成年人患有轻度至重度OSA的数字表明，该病既未被充分诊断又未被充分认识。该文件还强调指出，缺乏可用于估算OSA患病率和负担的质量证据。提供此类全局数据非常重要，因为该疾病（尤其是严重的OSA）与神经认知障碍，生活质量下降以及高血压，癌症以及新陈代谢，心血管和脑血管疾病的风险增加有关。